Clinical Trials on Skin Irritation

Total 49835 results

Zagazig University

Unknown

Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial

Psoriasis
Bausch Health Americas, Inc.

Terminated

Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Psoriasis

United States, Australia, France, Canada, Denmark
Amgen

Completed

Etanercept (Enbrel®) in Psoriasis - Pediatrics

Psoriasis
Cairo University

Unknown

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis

Psoriasis
Amgen

Completed

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Psoriasis

Australia, Canada, Hungary
Assiut University

Unknown

Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis

Psoriasis
Eli Lilly and Company

Completed

A Study of Ixekizumab in Participants With Plaque Psoriasis

Psoriasis

United States
Janssen Biotech, Inc.

Completed

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

Psoriasis
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)

Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate

Completed

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

Psoriasis

United States
Janssen Research & Development, LLC

Completed

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Psoriasis

United States, Canada, Poland
University of California, Davis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Withdrawn

Role of Chemokine and Chemokine Receptor in Psoriasis

Psoriasis

United States
Wake Forest University Health Sciences

Completed

Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab

Psoriasis

United States
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis
Amgen

Completed

Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

Psoriasis
Tianjin Hemay Bio-Tech Co., Ltd

Completed

Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects

Psoriasis

China
Promius Pharma, LLC

Completed

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Prothena Biosciences Limited

Completed

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

Psoriasis

United States
Kang Stem Biotech Co., Ltd.

Unknown

Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

Psoriasis

Korea, Republic of
Lina R. Khoury

Unknown

A Nurse-led Individualized Educational Intervention

Psoriasis

Denmark
GlaxoSmithKline
PPD; ERT: Clinical Trial Technology Solutions; Q2 Solutions

Withdrawn

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

Psoriasis
AbbVie

Terminated

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

Psoriasis

United States
Janssen Research & Development, LLC

Completed

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab (NAVIGATE)

Psoriasis

United States, Poland, United Kingdom, Germany, Taiwan, Spain, Australia, Canada, Korea, Republic of, Russian Federation
Centocor, Inc.

Completed

A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis

Psoriasis

United States
Janssen Pharmaceutical K.K.

Completed

A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis

Psoriasis

Japan
Illumicure Inc

Unknown

Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis

Psoriasis

United States
Genentech, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp (SCALP)

Psoriasis
Taro Pharmaceuticals USA

Completed

Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

Psoriasis
Eli Lilly and Company

Completed

A Safety Study of Mirikizumab (LY3074828)

Psoriasis

Canada
GlaxoSmithKline

Completed

Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis

Psoriasis

Germany
Merck Sharp & Dohme LLC

Completed

The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)

Psoriasis
University College Dublin

Completed

Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP) (DINUP)

Psoriasis

Ireland
Bausch Health Americas, Inc.

Completed

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Psoriasis

United States, Australia, New Zealand
Bayer

Completed

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Psoriasis

Germany
Genentech, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

Psoriasis
Janssen Biotech, Inc.

Completed

A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis (PSTELLAR)

Psoriasis

United States
Merck KGaA, Darmstadt, Germany

Completed

Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects

Psoriasis

Germany
Leon Kircik, M.D.
Stiefel, a GSK Company

Completed

Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis

Psoriasis

United States
Biopolis S.L.
Korott, S.L.

Completed

Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients

Psoriasis

Spain
University of Pittsburgh
LEO Pharma

Completed

A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy

Psoriasis

United States
Seoul National University Hospital

Completed

Comparison Study of Psoriasis Severity Assessment Tools

Psoriasis

Korea, Republic of
University of Aberdeen
NHS Grampian

Completed

Anti-psoriatic Effect of TL01 Light Therapy

Psoriasis

United Kingdom
Prothena Biosciences Limited

Completed

Single Ascending Dose Study of PRX003 in Healthy Subjects

Psoriasis

United States
Applied Biology, Inc.

Completed

Photocil (Topical) for the Treatment of Psoriasis Vulgaris

Psoriasis

United States
Hoffmann-La Roche

Completed

A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.

Psoriasis

Brazil
shmuel fuchs

Withdrawn

Influence of Atorvastatin on Psoriasis Severity and Endothelial Function

Psoriasis

Israel
Merck Sharp & Dohme LLC

Completed

Assessment of Long-Term Infliximab for Psoriasis (P05319) (REALITY)

Psoriasis
Maruho North America Inc.

Completed

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Psoriasis

United States
Maruho North America Inc.

Completed

Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Psoriasis

United States

3

Subscribe